» Articles » PMID: 32850745

A New Method for CTC Images Recognition Based on Machine Learning

Overview
Date 2020 Aug 28
PMID 32850745
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Circulating tumor cells (CTCs) derived from primary tumors and/or metastatic tumors are markers for tumor prognosis, and can also be used to monitor therapeutic efficacy and tumor recurrence. Circulating tumor cells enrichment and screening can be automated, but the final counting of CTCs currently requires manual intervention. This not only requires the participation of experienced pathologists, but also easily causes artificial misjudgment. Medical image recognition based on machine learning can effectively reduce the workload and improve the level of automation. So, we use machine learning to identify CTCs. First, we collected the CTC test results of 600 patients. After immunofluorescence staining, each picture presented a positive CTC cell nucleus and several negative controls. The images of CTCs were then segmented by image denoising, image filtering, edge detection, image expansion and contraction techniques using python's openCV scheme. Subsequently, traditional image recognition methods and machine learning were used to identify CTCs. Machine learning algorithms are implemented using convolutional neural network deep learning networks for training. We took 2300 cells from 600 patients for training and testing. About 1300 cells were used for training and the others were used for testing. The sensitivity and specificity of recognition reached 90.3 and 91.3%, respectively. We will further revise our models, hoping to achieve a higher sensitivity and specificity.

Citing Articles

Diagnostic test accuracy of AI-assisted mammography for breast imaging: a narrative review.

Dave D, Akhunzada A, Ivkovic N, Gyawali S, Cengiz K, Ahmed A PeerJ Comput Sci. 2025; 11:e2476.

PMID: 40062243 PMC: 11888881. DOI: 10.7717/peerj-cs.2476.


MRpoxNet: An enhanced deep learning approach for early detection of monkeypox using modified ResNet50.

Vandana , Sharma C, Shah M Digit Health. 2025; 11:20552076251320726.

PMID: 40013075 PMC: 11863262. DOI: 10.1177/20552076251320726.


Challenges issues and future recommendations of deep learning techniques for SARS-CoV-2 detection utilising X-ray and CT images: a comprehensive review.

Islam M, Al Farid F, Shamrat F, Islam M, Rashid M, Bari B PeerJ Comput Sci. 2025; 10:e2517.

PMID: 39896401 PMC: 11784792. DOI: 10.7717/peerj-cs.2517.


CTCNet: a fine-grained classification network for fluorescence images of circulating tumor cells.

Wu J, Wang H, Nie Y, Wang Y, He W, Wang G Med Biol Eng Comput. 2025; .

PMID: 39841310 DOI: 10.1007/s11517-025-03297-y.


Improving Circulating Tumor Cell Detection Using Image Synthesis and Transformer Models in Cancer Diagnostics.

Liang S, Bai X, Gu Y Sensors (Basel). 2024; 24(23).

PMID: 39686359 PMC: 11644996. DOI: 10.3390/s24237822.


References
1.
Le N, Huynh T, Yapp E, Yeh H . Identification of clathrin proteins by incorporating hyperparameter optimization in deep learning and PSSM profiles. Comput Methods Programs Biomed. 2019; 177:81-88. DOI: 10.1016/j.cmpb.2019.05.016. View

2.
Guibert N, Delaunay M, Lusque A, Boubekeur N, Rouquette I, Clermont E . PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab. Lung Cancer. 2018; 120:108-112. DOI: 10.1016/j.lungcan.2018.04.001. View

3.
Marcuello M, Vymetalkova V, Neves R, Duran-Sanchon S, Vedeld H, Tham E . Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med. 2019; 69:107-122. DOI: 10.1016/j.mam.2019.06.002. View

4.
Keller L, Werner S, Pantel K . Biology and clinical relevance of EpCAM. Cell Stress. 2019; 3(6):165-180. PMC: 6558934. DOI: 10.15698/cst2019.06.188. View

5.
Ferreira M, Ramani V, Jeffrey S . Circulating tumor cell technologies. Mol Oncol. 2016; 10(3):374-94. PMC: 5528969. DOI: 10.1016/j.molonc.2016.01.007. View